Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages.
Zha H, Wang X, Zhu Y, Chen D, Han X, Yang F, Gao J, Hu C, Shu C, Feng Y, Tan Y, Zhang J, Li Y, Wan YY, Guo B, Zhu B.
Zha H, et al. Among authors: guo b.
Cancer Immunol Res. 2019 Feb;7(2):193-207. doi: 10.1158/2326-6066.CIR-18-0272. Epub 2018 Dec 4.
Cancer Immunol Res. 2019.
PMID: 30514794